Effects of chronic peripheral pretreatment with an angiotensin II type-1 receptor blocker on apoptosis-related molecules in rats with cerebral ischemia/reperfusion injury

Jingping Shi,Jingde Dong,Jie Lu,Yingdong Zhang

DOI: https://doi.org/10.3969/j.issn.1673-5374.2010.15.005

2010-01-01

Neural Regeneration Research

Abstract:Chronic systemic treatment with blockers of angiotensin II type-1 (AT(1)) receptors inhibits ischemia-induced apoptosis and reduces ischemic neuronal damage. However, the molecular mechanisms of AT, receptor blockers in modulating neuronal apoptosis remain poorly understood. Pretreatment with irbesartan significantly suppressed cell apoptosis at 1-7 days following cerebral ischemia/reperfusion, increased levels of brain-derived neurotrophic factor, and elevated the ratios of Bcl-2/Bax and phosphorylated cyclic adenosine monophosphate response element-binding protein (pCREB)/CREB in the ischemic cortex at 1 day after reperfusion, as well as suppressing caspase-3 activation. Cerebral ischemia increased the mRNA expression of AT(1) and AT(2) receptors in the ischemic cortex, whereas irbesartan blocked this increase in AT(1) expression but potentiated the expression of AT(2). Therefore, this AT(1) receptor blocker was neuroprotective by increasing the ratios of Bcl-2/Bax and pCREB/CREB, increasing brain-derived neurotrophic factor levels, inhibiting caspase-3 activation, and modulating AT receptor expression.